Article
Seattle biotech startup born out of a Roche buyout lands $93M to advance therapies
Rating:
0.0
Views:
61
Likes:
1
Library:
1
Seattle biotech startup Bonum Therapeutics raised $93 million less than two months after its parent company Good Therapeutics was bought for $250 million by Roche, with the potential for milestone…
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value